Routine inpatient provider-initiated HIV testing in Malawi, compared with client-initiated community-based testing, identifies younger children at higher risk of early mortality

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 1, 2013, Pages

  Preidis, Geoffrey A ^a   McCollum, Eric D ^b,c   Kamiyango, William ^d   Garbino, Alejandro ^e   Hosseinipour, Mina C ^c   Kazembe, Peter N ^d   Schutze, Gordon E ^a   Kline, Mark W ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b Baylor International Pediatric AIDS Initiative   (Malawi)

^c UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^d Baylor Children's Foundation Malawi   (Malawi)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Africa; antiretroviral therapy; HIV testing; Malawi; pediatric HIV; pediatric hospitals

Indexed keywords

ARTICLE; CHILD; CLIENT INITIATED COMMUNITY BASED TESTING; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GROUPS BY AGE; HIGH RISK POPULATION; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INPATIENT PROVIDER INITIATED HIV TESTING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALAWI; MALE; MALNUTRITION; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PREDICTOR VARIABLE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD;

AIDS SERODIAGNOSIS; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HOSPITALS, PEDIATRIC; HUMANS; INPATIENTS; MALAWI; MALE; MALNUTRITION; MASS SCREENING; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84876283886     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318288aad6     Document Type: Article

References (35)

1. United Nations Children's Fund (UNICEF). Children and AIDS: Fifth Stocktaking Report 2010. New York, NY: UNICEF; 2010.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). Global Report: UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland: UNAIDS; 2010.
3. World Health Organization (WHO). Progress Report 2011: Global HIV/AIDS Response. Geneva, Switzerland: WHO; 2011.
4. Anabwani GM, Woldetsadik EA, Kline MW. Treatment of human immunodeficiency virus (HIV) in children using antiretroviral drugs. Semin Pediatr Infect Dis. 2005;16:116-124.
5. Kline MW. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment. Pediatrics. 2006;117:1388-1393.
6. Heidari S, Mofenson LM, Hobbs CV, et al. Unresolved antiretroviral treatment management issues in HIV-infected children. J Acquir Immune Defic Syndr. 2012;59:161-169.
7. Kabue MM, Chitsulo C, Kazembe PN, et al. A paediatric HIV care and treatment programme in Malawi. Malawi Med J. 2008;20:19-22.
8. McCollum ED, Preidis GA, Kabue MM, et al. Task shifting routine inpatient pediatric HIV testing improves program outcomes in urban Malawi: a retrospective observational study. PLoS One. 2010;5:e9626.
9. McCollum ED, Preidis GA, Golitko CL, et al. Routine inpatient human immunodeficiency virus testing system increases access to pediatric human immunodeficiency virus care in sub-Saharan Africa. Pediatr Infect Dis J. 2011;30:e75-e81.
10. Lowrance D, Filler S, Makombe S, et al. Assessment of a national monitoring and evaluation system for rapid expansion of antiretroviral treatment in Malawi. Trop Med Int Health. 2007;12:377-381.
11. Braun M, Kabue MM, McCollum ED, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:e122-e128.
12. Child Growth Standards Macro for SPSS. Geneva, Switzerland: World Health Organization; 2011. Available at: http://www.who.int/childgrowth/software/en/.
13. Weight-for-height, in % of the NCHS median, for children according to NCHS/CDC/WHO (1982) values. In: Weight for Height Reference Tables. Lilongwe, Malawi: Malawi Ministry of Health; Updated 1982.
14. Waxman MJ, Kimaiyo S, Ongaro N, et al. Initial outcomes of an emergency department rapid HIV testing program in western Kenya. AIDS Patient Care STDS. 2007;21:981-986.
15. Pope DS, Deluca AN, Kali P, et al. A cluster-randomized trial of provider-initiated (opt-out) HIV counseling and testing of tuberculosis patients in South Africa. JAcquir Immune Defic Syndr. 2008;48:190-195.
16. Creek TL, Ntumy R, Seipone K, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr. 2007;45:102-107.
17. Kankasa C, Carter RJ, Briggs N, et al. Routine offering of HIV testing to hospitalized pediatric patients at university teaching hospital, Lusaka, Zambia: acceptability and feasibility. J Acquir Immune Defic Syndr. 2009;51:202-208.
18. Wanyenze RK, Nawavvu C, Ouma J, et al. Provider-initiated HIV testing for paediatric inpatients and their caretakers is feasible and acceptable. Trop Med Int Health. 2010;15:113-119.
19. Bong CN, Yu JK, Chiang HC, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-1810.
20. Fetzer BC, Hosseinipour MC, Kamthuzi P, et al. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi. Trop Med Int Health. 2009;14:862-869.
21. Wamalwa DC, Obimbo EM, Farquhar C, et al. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort. BMC Pediatr. 2010;10:33.
22. Natural history of vertically acquired human immunodeficiency virus-1 infection. The European Collaborative Study. Pediatrics. 1994;94:815-819.
23. Aldhous MC, Raab GM, Mok JY, et al. CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr AIDS HIV Infect. 1996;7:20-30.
24. Halapi E, Leitner T, Jansson M, et al. Correlation between HIV sequence evolution, specific immune response and clinical outcome in vertically infected infants. AIDS. 1997;11:1709-1717.
25. Wasik TJ, Wierzbicki A, Whiteman VE, et al. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS. Eur J Immunol. 2000;30:117-127.
26. Zhang H, Hoffmann F, He J, et al. Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology. 2006;3:73.
27. Ferrand RA, Corbett EL, Wood R, et al. AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic. AIDS. 2009;23:2039-2046.
28. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N EnglJMed. 2008;359:2233-2244.
29. Thairu L, Katzenstein D, Israelski D. Operational challenges in delivering CD4 diagnostics in sub-Saharan Africa. AIDS Care. 2011;23:814-821.
30. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
31. Ekouevi DK, Azondekon A, Dicko F, et al. 12-month mortality and loss-to-program in antiretroviral-treated children: The IeDEA pediatric West African Database to evaluate AIDS (pWADA), 2000-2008. BMC Public Health. 2011;11:519.
32. Fatti G, Bock P, Eley B, et al. Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: an analysis in four provinces in South Africa, 2004-2009. J Acquir Immune Defic Syndr. 2011;58:e60-e67.
33. Anderson DA, Crowe SM, Garcia M. Point-of-care testing. Curr HIV/AIDS Rep. 2011;8:31-37.
34. Rollins N, Mzolo S, Moodley T, et al. Universal HIV testing of infants at immunization clinics: an acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS. 2009;23: 1851-1857.
35. McCollum ED, Johnson DC, Chasela CS, et al. Superior uptake and outcomes of early infant diagnosis of HIV services at an immunization clinic versus an "under-five" general pediatric clinic in Malawi. J Acquir Immune Defic Syndr. 2012;60:e107-e110.